CG Ting Wong, T Bottiglieri… - Annals of Neurology …, 2003 - Wiley Online Library
Abstract γAminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. GABA is converted from glutamic acid by the action of glutamic acid …
V Vengeliene, A Bilbao, A Molander… - British journal of …, 2008 - Wiley Online Library
Despite the generally held view that alcohol is an unspecific pharmacological agent, recent molecular pharmacology studies demonstrated that alcohol has only a few known primary …
A Mirijello, C D'Angelo, A Ferrulli, G Vassallo… - Drugs, 2015 - Springer
Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6–24 h after the abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …
NG Bowery, B Bettler, W Froestl, JP Gallagher… - Pharmacological …, 2002 - ASPET
The γ-aminobutyric acidB (GABAB) receptor was first demonstrated on presynaptic terminals where it serves as an autoreceptor and also as a heteroreceptor to influence transmitter …
Aims: The γ-aminobutyric acid (GABAB) receptor agonist, baclofen, has recently been shown to reduce alcohol intake in alcohol-preferring rats and alcohol consumption and …
Alcohol acts on numerous cellular and molecular targets to regulate neuronal communication within the brain. Chronic alcohol exposure and acute withdrawal generate …
M Heilig, M Egli - Pharmacology & therapeutics, 2006 - Elsevier
Alcoholism is a major public health problem and resembles, in many ways, other chronic relapsing medical conditions. At least 2 separate dimensions of its symptomatology offer …
BA Johnson - Biochemical pharmacology, 2008 - Elsevier
The past decade has seen an expansion of research and knowledge on pharmacotherapy for the treatment of alcohol dependence. The Food and Drug Administration (FDA)-approved …
Although it is evident from the literature that altered GABA B receptor function does affect behavior, these results often do not correspond well. These differences could be due to the …